AKEEGA
NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE
- Strength
- 500 mg/1, 50 mg/1
- Form
- Tablet, Film Coated
- Class
- Cytochrome P450 17A1 Inhibitor; Poly(AD…
Janssen Biotech, Inc.
Not stocked by us — reference only
AKEEGA
NIRAPARIB TOSYLATE MONOHYDRATE and ABIRATERONE ACETATE
Listed by Janssen Biotech, Inc.
- Strength
- 500 mg/1, 100 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Cytochrome P450 17A1 Inhibitor; Poly(ADP-Ribo…
What it contains
- Niraparib Tosylate Monohydrate 500 mg/1
- Abiraterone Acetate 100 mg/1
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Cytochrome P450 17A1 Inhibitor; Poly(ADP-Ribose) Polymerase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 57894-100 |
| FDA application | NDA216793 |
| RxNorm concept | 2645244 |
| Package sizes listed | 1 |
| Marketed since | August 2023 |
Other products containing Niraparib Tosylate
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ZEJULA
niraparib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Poly(ADP-Ribose) Polymerase Inhibitor
GlaxoSmithKline LLC
Not stocked by us — reference only
ZEJULA
niraparib
- Strength
- 300 mg/1
- Form
- Tablet, Film Coated
- Class
- Poly(ADP-Ribose) Polymerase Inhibitor
GlaxoSmithKline LLC
Not stocked by us — reference only
ZEJULA
niraparib
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Poly(ADP-Ribose) Polymerase Inhibitor
GlaxoSmithKline LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.